The Benaroya Research Institute at Virginia Mason (BRI) is a center of scientific excellence in research and therapy of autoimmune diseases, such as diabetes and arthritis, and promotes clinical and interdisciplinary research, particularly in cancer, neuroscience, and heart disease. A not-for-profit organization, BRI is funded through support from government, corporate, philanthropic donors and associations. BRI offers a competitive salary and excellent benefits.
